DaVita (DVA)
(Delayed Data from NYSE)
$137.95 USD
+1.89 (1.39%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $137.99 +0.04 (0.03%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth B Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
DVA 137.95 +1.89(1.39%)
Will DVA be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for DVA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DVA
DaVita HealthCare (DVA) Rises Higher Than Market: Key Facts
DaVita (DVA) Gains 29.8% YTD: What's Driving the Stock?
DVA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Patterson Companies (PDCO) Aims to Streamline Patient Experience
Terumo (TRUMY) Unit's SOFAST Study Shows Positive Results
Alcon (ALC) Rides on Innovation, Balanced Segmental Sales
Other News for DVA
Financial Crime Weekly: DaVita Agrees To Pay $34.5M For Kickbacks, Hospice Provider Doles Out $19.4M For False Claims
DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call
FHLC: Healthcare Dashboard For July
DaVita (DVA) Gets a Hold from Barclays
Long-term beneficiaries of AI, according to Goldman Sachs